Stomach Cancer Clinical Trial
Official title:
Phase III Study on Comparison for Bile Reflux and Gastric Stasis in Patients With Gastric Cancer After Distal Gastrectomy
The purpose of this study is to evaluate the degree of bile reflux and gastric stasis according the reconstruction methods after distal subtotal gastrectomy for gastric cancer, and to find out the proper method. We collect ninety patients who undergo distal gastrectomy for gastric cancers for this study from 5 institutions and randomly divide into 3 groups according to reconstruction methods: 1) Billroth-II (B-II), 2) Roux en Y gastrojejunostomy (RY-GJ) and 3) uncut Roux en Y gastrojejunostomy (uncut RY-GJ).
Patients who have undergone gastrectomy for gastric cancer might be developed various
symptoms by gastric stasis and bile reflux, it so called "post-gastrectomy syndrome",
because of the diminishment of stomach capacity, the decrease of expulsive ability and the
change of food passage. Until now, that had been accepted as the inevitable results after
gastric resection. However, the survival rate has recently been increased owing to the
increased proportion of early gastric cancer. And thus, to improve the quality of life of
patients, many researchers have been actually studying for the reconstruction methods which
are able to minimize the symptom by gastrectomy, but it is dissatisfied until now. Thus, the
purpose of this study is to evaluate the degree of bile reflux and gastric stasis according
the reconstruction methods after distal subtotal gastrectomy for gastric cancer, and to find
out the proper method.
We collect ninety patients who undergo distal gastrectomy for gastric cancers for this study
from 5 institutions and randomly divide into 3 groups according to reconstruction methods:
1) Billroth-II (B-II), 2) Roux en Y gastrojejunostomy (RY-GJ) and 3) uncut Roux en Y
gastrojejunostomy (uncut RY-GJ). We evaluate the postoperative morbidity rate and then the
degree of bile reflux, gastric emptying time and quality of life through long term follow-up
using the gastrofiberscope, survey and so on.
From this study, we would suggest the standard reconstruction procedure after distal
gastrectomy.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Completed |
NCT02604979 -
The Influences of Long Periods of Pneumoperitoneum and Head up Position on the Variation of Heart-rate Corrected QT Interval During Robotic-assisted Laparoscopic Gastrectomy - Observational Study
|
N/A | |
Active, not recruiting |
NCT00394433 -
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
|
Phase 2 | |
Completed |
NCT00201747 -
Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
|
Phase 2 | |
Completed |
NCT00215514 -
Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma
|
Phase 0 | |
Recruiting |
NCT04486651 -
HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
|
Phase 3 | |
Recruiting |
NCT05415475 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT04526470 -
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT01257711 -
A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
|
N/A | |
Recruiting |
NCT04907643 -
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
|
N/A | |
Withdrawn |
NCT03704077 -
An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
|
Phase 2 | |
Recruiting |
NCT05489250 -
The PLATON Network
|
||
Recruiting |
NCT04484636 -
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
|
N/A | |
Completed |
NCT02547064 -
Effect of Modified Stylet Angulation on the Intubation With GlideScope®
|
N/A | |
Withdrawn |
NCT00800969 -
Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach
|
Phase 2 | |
Completed |
NCT00296322 -
Trial of Adjuvant Chemotherapy for Gastric Cancer
|
Phase 3 | |
Recruiting |
NCT04215861 -
Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy
|
||
Recruiting |
NCT06199895 -
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
|
Phase 2 | |
Recruiting |
NCT01038154 -
Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer
|
Phase 4 |